TORPEdO – A Phase III Trial of Intensity-modulated Proton Beam Therapy Versus Intensity-modulated Radiotherapy for Multi-toxicity Reduction in Oropharyngeal Cancer

TORPEdO (TOxicity Reduction using Proton bEam therapy for Oropharyngeal cancer) is the UK's first proton clinical trial. It is a multicentre phase III trial of intensity-modulated proton beam therapy (IMPT) versus intensity-modulated radiotherapy (IMRT) for oropharyngeal squamous cell carcinoma (OPSCC).

Source: Clinical Oncology - October 7, 2019 Category: Radiology Authors: J. Price, E. Hall, C. West, D. Thomson Tags: Editorial Source Type: research